Lucid Diagnostics (LUCD) Stock News
$LUCD · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Lucid Diagnostics (LUCD) in the past 30 days. BORSA’s news read on LUCD is balanced at 50/100, unchanged over 24 hours, based on 1 company event over the past 7 days. LUCD last closed at $0.43 on Oct 29, up 31.92% over five sessions and down 42.44% over the past month. Lucid Diagnostics’ next earnings report is scheduled for Thursday, Nov 12 before the open.
The wire on $LUCD
newest first · updated · direct subject stories onlyLucid Diagnostics will host a business update conference call and webcast on November 12, 2026, at 8:30 a.m. ET. CEO Lishan Aklog will discuss operations and growth strategy, and CFO Dennis McGrath will review third-quarter 2026 financial results. The webcast will be available on the company's investor relations website, with a telephone dial-in and a 30-day replay.
neutral 50 · impact 10BTIG has maintained its price target for Lucid Diagnostics at $2.50 per share.
neutral 50 · impact 20The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.